SCHEMBL30656385

SCHEMBL30656385

COC(=O)c1c(C=O)sc2ccc(Br)cc12

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 6/20 0.44
TDP1 Q9NUW8 1/20 0.44
TSHR P16473 2/20 0.43
HTT P42858 1/20 0.43
PFKFB3 Q16875 1/20 0.43
PFKFB4 Q16877 1/20 0.43
NR4A2 P43354 1/20 0.42
LMNA P02545 2/20 0.41
MAPK1 P28482 1/20 0.41
CYP2A6 P11509 1/20 0.40
UBE2N P61088 1/20 0.39
ATM Q13315 1/20 0.39
TLR9 Q9NR96 1/20 0.39
PRKCZ Q05513 1/20 0.37
MAPT P10636 2/20 0.37
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26661118 1.00 L3MBTL1 (0.44) L3MBTL1TDP1TSHRHTTPFKFB3
SCHEMBL31351339 0.86 L3MBTL1 (0.46) L3MBTL1TDP1TSHRHTTLMNA
SCHEMBL26661109 0.86 L3MBTL1 (0.46) L3MBTL1TDP1TSHRHTTLMNA
SCHEMBL31351348 0.81 LMNA (0.63) L3MBTL1TDP1TSHRHTTPFKFB3
SCHEMBL26661107 0.81 LMNA (0.63) L3MBTL1TDP1TSHRHTTPFKFB3
SCHEMBL26661127 0.79 LMNA (0.52) L3MBTL1TDP1TSHRHTTPFKFB3
SCHEMBL30656383 0.79 LMNA (0.52) L3MBTL1TDP1TSHRHTTPFKFB3
SCHEMBL2469455 0.78 TSHR (0.43) L3MBTL1TDP1TSHRHTTPFKFB3
SCHEMBL26661110 0.76 LMNA (0.52) L3MBTL1TDP1TSHRHTTPFKFB3
SCHEMBL30656186 0.75 L3MBTL1 (0.38) L3MBTL1TDP1LMNAMAPK1UBE2N

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP disclosed
CN-119421879-A Novel derivatives for the treatment of TRPM3 mediated disorders 勒芬天主教大学 2025-02-11 CN disclosed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed